Back
Sarepta Therapeutics Stock Predictions

Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
SRPT
Sarepta Therapeutics
Last Price:
$53.80
Seasonality Move:
13.2%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Sarepta Therapeutics Stock Forecast
-
Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 26.6% based on the past 27 years of stock performance.
-
Sarepta Therapeutics has risen higher in 12 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Sarepta Therapeutics Stock Undervalued?The current Sarepta Therapeutics [SRPT] share price is $53.79. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Sarepta Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 26.6% based on the past 27 years of stock performance.
Sarepta Therapeutics Stock Rating
Buy
57
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics overpriced?
-
Sarepta Therapeutics has risen higher in 12 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Sarepta Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com
52-Week Data
52-Week High:
173.25
52-Week Low:
48.01
Prediction Charts
Market Cap:
5.2B
Price in USD:
53.79
Volume:
1.9M
Beta:
1.09
Technical Analysis
SMA50:
86.36
SMA100:
103.88
SMA200:
118.53
52-Wk Change:
-54.37%
Stock Predictions
-
Is Sarepta Therapeutics stock public?Yes, Sarepta Therapeutics is a publicly traded company.
-
What is the Sarepta Therapeutics stock quote today?The Sarepta Therapeutics stock price is 53.79 USD today.
-
How to buy Sarepta Therapeutics stock online?You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Mar-31 | 65.90 | 63.82 | 67.47 | 62.50 |
Apr-1 | 64.37 | 61.91 | 65.69 | 61.53 |
Apr-2 | 61.69 | 62.47 | 64.23 | 60.70 |
Apr-3 | 57.22 | 58.61 | 60.24 | 57.14 |
Apr-4 | 59.22 | 54.43 | 59.45 | 54.26 |
Apr-7 | 51.59 | 52.40 | 55.17 | 50.61 |
Apr-8 | 53.99 | 49.30 | 55.36 | 48.94 |
Apr-9 | 48.55 | 55.65 | 57.70 | 48.01 |
Apr-10 | 53.34 | 50.31 | 54.47 | 49.86 |
Apr-11 | 51.22 | 51.03 | 51.80 | 49.09 |
Apr-14 | 53.34 | 54.63 | 54.64 | 51.39 |
Apr-15 | 54.09 | 54.42 | 56.34 | 53.23 |
Apr-16 | 54.59 | 53.94 | 55.01 | 53.02 |
Apr-17 | 53.70 | 53.79 | 55.49 | 53.56 |
Sarepta Therapeutics Earnings
Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sarepta Therapeutics Forecast Revenue Growth
Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.98 per share, and an increase next year of $6.27 per share.
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.